● Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Condition: High-grade Serous Ovarian Carcinoma (HGSOC) · Uterine Serous Carcinoma (USC) · Non-small Cell Lung Cancer (NSCLC) · Sponsor: Bristol-Myers Squibb

PhasePhase 1

Planned participants240

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety, tolerability, and efficacy of escalating doses of BMS-986463 in participants with select advanced malignant tumors.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (17)

USC/Norris Comprehensive Cancer Center	Los Angeles, California, United States	Recruiting
Valkyrie Clinical Trials	Los Angeles, California, United States	Recruiting
John Theurer Cancer Center at Hackensack University Medical Center	Hackensack, New Jersey, United States	Recruiting
Local Institution - 0045	Columbus, Ohio, United States	Not Yet Recruiting
Local Institution - 0046	Dallas, Texas, United States	Withdrawn
Local Institution - 0049	Houston, Texas, United States	Not Yet Recruiting
BC Cancer Vancouver	Vancouver, British Columbia, Canada	Recruiting
Princess Margaret Cancer Centre	Toronto, Ontario, Canada	Recruiting
Centre Hospitalier de l'Université de Montréal	Montreal, Quebec, Canada	Recruiting
Jewish General Hospital	Montreal, Quebec, Canada	Recruiting
Local Institution - 0036	Bordeaux, Aquitaine, France	Not Yet Recruiting
Local Institution - 0031	Villejuif, Val-de-Marne, France	Not Yet Recruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06476808